TP53 and colon adenocarcinoma: From this study, xanthone 52 (Figure 12) was identified as a putative p53-activating agent, inhibiting the growth of human colon adenocarcinoma HCT116 cell line, being this effect associated with cell cycle arrest through activation of the p53 pathway.